David A. Katzenstein, MD - Medical Marijuana

Last updated on: 10/4/2007 | Author:

David A. Katzenstein, MD Biography

Title:

Associate Medical Director of the Stanford University AIDS Clinical Trial Group

Position:

Pro to the question "Should Marijuana Be a Medical Option?"

Reasoning:

“[I]t is clear that there are people who use marijuana solely to ameliorate symptoms associated with chronic disease, such as HIV/AIDS. This suggests that cannabinoids have potential benefit as a therapeutic class of agents.”

Feb. 2004

Involvement and Affiliations:

Associate Medical Director, Stanford University AIDS Clinical Trial Group, 1997-present
Co-Director, Diagnostic Virology Laboratory, Stanford University, 1997-present
Associate Professor, Division of Infectious Diseases, Stanford University, 1997-present
Recipient, Doris Duke Distinguished Clinical Scientist Award, Affordable Feasible Treatment for HIV infected Women in Southern Africa, 2000

Education:

Fellowship, Infectious Diseases, University of California, Davis, 1983
Fellowship, Infectious Diseases, University of California, San Diego, 1981
Residency, Internal Medicine, University of Davis, 1980
Internship, Internal Medicine, University of New Mexico, 1978
MD, University of California, San Diego, 1977
BA, University of California, San Diego, 1972

Other:

None found